Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jun 24 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-0.72 Insider Own36.91% Shs Outstand17.46M Perf Week-7.11%
Market Cap1.27M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float1.11M Perf Month-40.98%
Income-11.49M PEG- EPS next Q- Inst Own7.08% Short Float1.43% Perf Quarter-47.82%
Sales0.02M P/S63.36 EPS this Y- Inst Trans- Short Ratio0.01 Perf Half Y-68.55%
Book/sh0.00 P/B156.52 EPS next Y- ROA-220.32% Short Interest0.02M Perf Year-93.79%
Cash/sh0.12 P/C6.03 EPS next 5Y- ROE- 52W Range0.44 - 12.80 Perf YTD-71.88%
Dividend Est.- P/FCF- EPS past 5Y- ROI-1435.56% 52W High-94.37% Beta1.42
Dividend TTM- Quick Ratio0.38 Sales past 5Y0.00% Gross Margin-673.85% 52W Low63.49% ATR (14)0.12
Dividend Ex-Date- Current Ratio0.38 EPS Y/Y TTM- Oper. Margin-41005.83% RSI (14)40.63 Volatility8.93% 13.34%
Employees- Debt/Eq17.00 Sales Y/Y TTM- Profit Margin-68682.91% Recom1.00 Target Price14.00
Option/ShortNo / Yes LT Debt/Eq9.00 EPS Q/Q-78.19% Payout- Rel Volume0.01 Prev Close0.68
Sales Surprise- EPS Surprise-15.15% Sales Q/Q- Earnings- Avg Volume1.21M Price0.72
SMA20-13.03% SMA50-22.07% SMA200-70.00% Trades Volume16,430 Change5.26%
May-28-24 04:05PM
May-26-24 09:10PM
May-16-24 12:08PM
May-08-24 07:31AM
04:05PM Loading…
Feb-16-24 04:05PM
Oct-18-23 07:00AM
Sep-26-23 08:30AM
Sep-20-23 08:30AM
Sep-15-23 09:30AM
Sep-13-23 01:37AM
Sep-12-23 11:20PM
Sep-08-23 08:30AM
01:39AM Loading…
Sep-07-23 10:30AM
Jul-31-23 06:00AM
Jul-20-23 08:40AM
Jul-14-23 09:13AM
Jul-13-23 09:14AM
Jul-11-23 09:00AM
Jul-05-23 09:00AM
Jun-30-23 09:28AM
Jun-29-23 02:50PM
Jun-09-23 04:48PM
04:30PM Loading…
Jun-06-23 04:30PM
Jun-05-23 09:00AM
May-22-23 09:00AM
May-19-23 02:50PM
May-18-23 09:00AM
Apr-06-23 09:00AM
Mar-29-23 09:00AM
Mar-27-23 12:49PM
Mar-23-23 09:00AM
Mar-21-23 09:00AM
Mar-17-23 09:00AM
Feb-27-23 10:25AM
Feb-22-23 09:00AM
Feb-16-23 03:45PM
Feb-13-23 04:05PM
Feb-08-23 05:40PM
Lucy Scientific Discovery, Inc. is an early-stage company, which engages in the manufacture of psychotropics contracts. It focuses on the research, development, and manufacture of psychotropics-based medicines. Its products include raw materials, crude extracts, targeted formulations, white and private label products, and single molecule fractions. The company was founded on February 17, 2017 and is headquartered in Victoria, Canada.